Home/Filings/4/0000950170-24-072426
4//SEC Filing

Rubin Jami 4

Accession 0000950170-24-072426

CIK 0001812364other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 4:06 PM ET

Size

7.0 KB

Accession

0000950170-24-072426

Insider Transaction Report

Form 4
Period: 2024-06-10
Rubin Jami
Director
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-06-1042,2420 total
    Exercise: $5.04Exp: 2029-10-09Common Stock (42,242 underlying)
  • Exercise/Conversion

    Common Stock

    2024-06-10$5.04/sh+42,242$212,90067,242 total
Footnotes (2)
  • [F1]This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.
  • [F2]This stock option vested in sixteen (16) equal quarterly installments following the vesting commencement date of October 10, 2019, subject to the reporting person's continued service relationship through each vesting date.

Documents

1 file

Issuer

Relay Therapeutics, Inc.

CIK 0001812364

Entity typeother

Related Parties

1
  • filerCIK 0001816484

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:06 PM ET
Size
7.0 KB